$2,959.64 travel Payment -- Novartis Pharmaceuticals to Dr. Steven Green
Novartis Pharmaceuticals Pays Cardiology Specialist Steven Green $2959.64 for Travel Related to Humira
This page provides a detailed analysis of a $2,959.64 travel payment from Novartis Pharmaceuticals to Dr. Steven Green. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $2,959.64 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Novartis Pharmaceuticals |
| Physician | Dr. Steven Green |
| NPI Number | 1372906823 |
| Physician Specialty | Cardiology |
| Location | City, TN |
| Date of Payment | 2025-10-25 |
| Related Drug/Device | Humira |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Novartis Pharmaceuticals made a $3.0K travel payment to Steven Green, a Cardiology specialist in City, TN. The payment was associated with Humira. The payment of $2959.64 to Dr. Steven Green from Novartis Pharmaceuticals for travel and lodging related to Humira is a significant amount for a single payment. The payment was made on October 25, 2025, indicating a recent transaction. The specialty of Cardiology and the drug Humira suggest the travel may be related to medical education or research concerning this specific medication.
Patient Guidance: What This Payment Means for You
This payment was for travel and lodging expenses. It's important to understand how such payments might influence medical recommendations. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
While travel payments are common in cardiology, the amount of $2959.64 for a single instance of travel and lodging may be higher than average, warranting further context on the nature of the travel.
Regulatory Context: Sunshine Act Requirements
Payments for travel and lodging are reportable under the Sunshine Act, requiring disclosure to ensure transparency in physician-pharma relationships.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- cardiology
- humira
- novartis-pharmaceuticals
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $3.0K payment for?
This was a travel payment of $3.0K from Novartis Pharmaceuticals to Steven Green, categorized as "Travel and Lodging". It was associated with Humira. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Steven Green accept pharmaceutical money?
Yes, Steven Green received this $3.0K payment from Novartis Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Steven Green's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $3.0K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Cardiology?
To compare this payment against Cardiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Cardiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Steven Green's relationship with Novartis Pharmaceuticals?
The payment covers 'Travel and Lodging', suggesting expenses incurred by the physician. This $3.0K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Cardiology?
The specific drug mentioned is Humira, a biologic medication often used for autoimmune conditions.
What should patients do after learning about this payment?
This payment was for travel and lodging expenses. It's important to understand how such payments might influence medical recommendations.
What else should I know about this travel payment?
The payment ID 'OP-MNK3Y11I-MRE270' allows for specific tracking of this transaction.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.